Bellerophon Therapeutics Price Prediction
| BLPHDelisted Stock | USD 0.71 0.01 1.43% |
Oversold Vs Overbought
22
Oversold | Overbought |
Using Bellerophon Therapeutics hype-based prediction, you can estimate the value of Bellerophon Therapeutics from the perspective of Bellerophon Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Bellerophon Therapeutics to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Bellerophon because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Bellerophon Therapeutics after-hype prediction price | USD 0.71 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Bellerophon |
Bellerophon Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Bellerophon Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Bellerophon Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Bellerophon Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Bellerophon Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Bellerophon Therapeutics' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Bellerophon Therapeutics' historical news coverage. Bellerophon Therapeutics' after-hype downside and upside margins for the prediction period are 0.71 and 0.71, respectively. We have considered Bellerophon Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Bellerophon Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Bellerophon Therapeutics is based on 3 months time horizon.
Bellerophon Therapeutics Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Bellerophon Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bellerophon Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Bellerophon Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 7 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.71 | 0.71 | 0.00 |
|
Bellerophon Therapeutics Hype Timeline
Bellerophon Therapeutics is currently traded for 0.71. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Bellerophon is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Bellerophon Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 0.71. About 45.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.05. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bellerophon Therapeutics recorded a loss per share of 0.34. The entity last dividend was issued on the 10th of February 2020. The firm had 1:15 split on the 10th of February 2020. Given the investment horizon of 90 days the next projected press release will be in 5 to 10 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.Bellerophon Therapeutics Related Hype Analysis
Having access to credible news sources related to Bellerophon Therapeutics' direct competition is more important than ever and may enhance your ability to predict Bellerophon Therapeutics' future price movements. Getting to know how Bellerophon Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Bellerophon Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BPTH | Bio Path Holdings | (0.02) | 9 per month | 0.00 | (0.05) | 6.90 | (8.08) | 51.22 | |
| CBIO | Catalyst Biosciences | 0.01 | 2 per month | 4.45 | 0.15 | 9.76 | (8.33) | 38.47 | |
| DFFN | Diffusion Pharmaceuticals | 0.1 | 5 per month | 0.00 | (0.21) | 4.09 | (5.32) | 12.34 | |
| CAPR | Capricor Therapeutics | 0.53 | 11 per month | 5.84 | 0.20 | 18.22 | (10.45) | 75.82 | |
| NXTC | NextCure | (0.05) | 5 per month | 0.00 | (0.10) | 5.22 | (5.52) | 21.68 | |
| ZURA | Zura Bio Limited | (0.16) | 8 per month | 0.00 | (0.07) | 7.95 | (8.08) | 26.70 | |
| CYTO | Altamira Therapeutics | (0.01) | 7 per month | 0.00 | (0.19) | 7.50 | (10.87) | 22.81 | |
| IMMX | Immix Biopharma | (0.14) | 5 per month | 5.00 | 0.04 | 11.44 | (8.72) | 32.68 | |
| ENVB | Enveric Biosciences | 0.01 | 6 per month | 0.00 | (0.11) | 8.00 | (7.50) | 28.33 | |
| PALI | Palisade Bio | (0.10) | 6 per month | 0.00 | (0.23) | 5.97 | (10.21) | 34.14 |
Bellerophon Therapeutics Additional Predictive Modules
Most predictive techniques to examine Bellerophon price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bellerophon using various technical indicators. When you analyze Bellerophon charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Bellerophon Therapeutics Predictive Indicators
The successful prediction of Bellerophon Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Bellerophon Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Bellerophon Therapeutics based on analysis of Bellerophon Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Bellerophon Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Bellerophon Therapeutics's related companies.
Story Coverage note for Bellerophon Therapeutics
The number of cover stories for Bellerophon Therapeutics depends on current market conditions and Bellerophon Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bellerophon Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bellerophon Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Bellerophon Therapeutics Short Properties
Bellerophon Therapeutics' future price predictability will typically decrease when Bellerophon Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bellerophon Therapeutics often depends not only on the future outlook of the potential Bellerophon Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bellerophon Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 9.6 M | |
| Cash And Short Term Investments | 6.9 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Bellerophon Pink Sheet
If you are still planning to invest in Bellerophon Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellerophon Therapeutics' history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |